• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Amazon announces Health Condition Programs for digital health access.

Share:

January 14, 2024

Amazon has unveiled its Health Condition Programs at the JPM Healthcare Conference, collaborating with Omada Health as the launch partner. The initiative allows customers to access digital health tools through their employer or insurance carrier, focusing on managing chronic conditions like diabetes, prediabetes, and high blood pressure. Omada Health provides personalized data-driven behavior change coaching, enabling users to monitor exercise, diet, blood glucose, and more. Amazon intends to expand the program by partnering with additional digital health companies in the future.

At the JPM Healthcare Conference in San Francisco, Amazon announced the launch of its new Health Condition Programs, which allow customers to tap into digital health benefits offered through their employer or insurance carrier, with chronic care management company Omada Health as the company’s launch partner.

Amazon aims to help individuals access digital health tools that can help them manage chronic conditions, such as diabetes, prediabetes and high blood pressure.

Founded in 2011, Omada got its start in prediabetes management; however, the company’s services have evolved to include services to help manage diabetes, hypertension, and musculoskeletal conditions.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The San Francisco-based organization focuses on aiding individuals in managing their health conditions through personalized data-driven behavior change coaching. The platform can also help users keep track of their exercise, diet, blood glucose and other metrics. Patients can access virtual care for support through the platform as well.

Eligible members of Omada can enroll in the company’s programs for diabetes, diabetes prevention and hypertension through Amazon.

Individuals can check their eligibility for the program on the Amazon Health webpage.

Amazon said it intends to expand its Health Conditions Programs by partnering with more digital health companies.

“Amazon wants to make it easier for people to get and stay healthy, and part of that is making it easier to discover the products, services and professionals that can help them do that. Many people aren’t aware of the health care benefits they’re eligible for, that are typically no cost or subsidized by their employer or insurance plan,” Aaron Martin, vice president of healthcare at Amazon, said in a statement.

“When customers are shopping for health-related products on Amazon, we can surface these additional health care benefits to them to provide even more support in improving their health, at no additional cost.”

THE LARGER TREND

Amazon has long been in the business of advancing digital health.

The company launched Amazon Care in 2019, a virtual clinic for its own employees, and the service later expanded to outside employers.

In 2022, however, it shut down Care because, according to senior vice president of Amazon Health Services Neil Lindsay, the telehealth service was “not a complete enough offering for the large enterprise customers we have been targeting, and wasn’t going to work long-term.”

The same year Care closed, Amazon launched Amazon Clinic, a virtual care platform that delivers care for numerous common conditions, including hair loss, heartburn, acne, dandruff and seasonal allergies.

The company also announced it signed a definitive agreement to purchase One Medical for $3.9 billion in 2022. Several months later, the tech and retail giant said the deal was under review by the Federal Trade Commission.

Last year, Amazon closed its billion-dollar acquisition of the primary care provider. At the time, the Federal Trade Commission issued a statement that said it wouldn’t block the deal but would continue its investigation.

The company also announced partnerships between One Medical and Employee-focused care navigation and pharmacy benefits platform Rightway last year and with Maven Clinic, which offers virtual care geared toward women and families.

Meanwhile, in 2022, Omada scored a whopping $192 million in Series E funding, bringing its total raise to more than $256 million

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Virta Health Raises $93M to Expand Clinically Proven Treatment to Reverse Type 2 DiabetesVirta Health Raises $93M to Expand Clinically Proven Treatment to Reverse Type 2 Diabetes
  • EMPATHIQ Acquires Patient Experience & Reputation Platform RivewsEMPATHIQ Acquires Patient Experience & Reputation Platform Rivews
  • ICU Medical, Inc. to Acquire Smiths Medical Division from Smiths Group Plc for $2.35 Billion in Cash and Stock Plus the Assumption of Certain Liabilities and a Stock Price Performance-Based Earn-OutICU Medical, Inc. to Acquire Smiths Medical Division from Smiths Group Plc for $2.35 Billion in Cash and Stock Plus the Assumption of Certain Liabilities and a Stock Price Performance-Based Earn-Out
  • Top 10 Trends In The Medical Device And Equipment IndustryTop 10 Trends In The Medical Device And Equipment Industry
  • Scanwell Health Announces Nationwide Launch of Smartphone-Enabled Test and Treatment Service for Urinary Tract Infections via Partnership with Lemonaid HealthScanwell Health Announces Nationwide Launch of Smartphone-Enabled Test and Treatment Service for Urinary Tract Infections via Partnership with Lemonaid Health
  • Two Labs Acquires CEEK EnterprisesTwo Labs Acquires CEEK Enterprises
  • Nymox Pharmaceutical Receives Potential Delisting Notice From NasdaqNymox Pharmaceutical Receives Potential Delisting Notice From Nasdaq
  • State-Specific COVID-19 Vaccine Information is Confusing. Facebook says It can HelpState-Specific COVID-19 Vaccine Information is Confusing. Facebook says It can Help

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications